CERO THERAPEUTICS HOLDINGS, INC. (CERO) Executive Compensation
CERO THERAPEUTICS HOLDINGS, INC. (CERO) is a publicly traded company on the OTC, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CERO
CIK: 1870404
Exchange: OTC
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Salberg & Company, P.A.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerScott Salberg
Audit LocationBoca Raton, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-07 | 2026-10-06 | CURRENT REPORT | 0001213900-26-107410 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-27 | CURRENT REPORT | 0001213900-26-095776 | View SEC Doc Filr Page |
| 424B3 | 2026-08-14 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-090061 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-090030 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001376474-26-000565 | View SEC Doc Filr Page |
| 424B3 | 2026-07-17 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-079223 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-14 | CURRENT REPORT | 0001213900-26-079207 | View SEC Doc Filr Page |
| 25-NSE | 2026-07-13 | — | 25-NSE Filing | 0001354457-26-000670 | View SEC Doc Filr Page |
| 424B3 | 2026-06-26 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-072609 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-23 | CURRENT REPORT | 0001213900-26-072602 | View SEC Doc Filr Page |
| 424B3 | 2026-05-29 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-062837 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-28 | CURRENT REPORT | 0001213900-26-062802 | View SEC Doc Filr Page |
| 424B3 | 2026-05-15 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-057853 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-057753 | View SEC Doc Filr Page |
| 424B3 | 2026-05-01 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-050953 | View SEC Doc Filr Page |
| 8-K | 2026-05-01 | 2026-04-27 | CURRENT REPORT | 0001213900-26-050951 | View SEC Doc Filr Page |
| 424B3 | 2026-05-01 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-050932 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-30 | 2025-12-31 | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-26-050302 | View SEC Doc Filr Page |
| 4 | 2026-04-21 | 2026-03-04 | 4 Filing | 0001213900-26-046329 | View SEC Doc Filr Page |
| 3 | 2026-04-21 | 2026-02-13 | 3 Filing | 0001213900-26-046328 | View SEC Doc Filr Page |
| 424B3 | 2026-04-15 | — | PROSPECTUS SUPPLEMENT NO. 8 | 0001213900-26-044124 | View SEC Doc Filr Page |
| 10-K | 2026-04-15 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-044040 | View SEC Doc Filr Page |
| 424B3 | 2026-04-14 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-043520 | View SEC Doc Filr Page |
| 8-K | 2026-04-14 | 2026-04-08 | CURRENT REPORT | 0001213900-26-043519 | View SEC Doc Filr Page |
| NT 10-K | 2026-04-01 | 2025-12-31 | NOTIFICATION OF LATE FILING | 0001213900-26-038509 | View SEC Doc Filr Page |